Orthostatic stability with intravenous levodopa
Intravenous levodopa has been used in a multitude of research studies due to its more predictable pharmacokinetics compared to the oral form, which is used frequently as a treatment for Parkinson’s disease (PD). Levodopa is the precursor for dopamine, and intravenous dopamine would strongly affect v...
Main Authors: | Shan H. Siddiqi, Mary L. Creech, Kevin J. Black |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2015-08-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/1198.pdf |
Similar Items
-
The human experience with intravenous levodopa
by: Shan H Siddiqi, et al.
Published: (2016-01-01) -
An updated calculator for determining levodopa-equivalent dose
by: D. Nyholm, et al.
Published: (2021-10-01) -
Ascorbic acid can alleviate the degradation of levodopa and carbidopa induced by magnesium oxide
by: Noriyuki Miyaue, et al.
Published: (2022-07-01) -
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease
by: Michael J. Soileau, et al.
Published: (2023-01-01) -
Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson’s disease: Post-hoc analyses from a large 54-week trial
by: Rajesh Pahwa, et al.
Published: (2023-01-01)